Skip to main content
Evome Medical Technologies Inc. logo

Evome Medical Technologies Inc. — Investor Relations & Filings

Ticker · EVMT ISIN · CA30053H1055 TSXV Manufacturing
Open in API
Filings indexed 403 across all filing types
Latest filing 2022-09-26 Capital/Financing Update
Country CA Canada
Listing TSXV EVMT

About Evome Medical Technologies Inc.

https://www.evomemedical.com

Evome Medical Technologies Inc. is a medical device enterprise dedicated to the design, development, production, and distribution of specialized medical devices. The company's core business centers on human performance and rehabilitative solutions, specifically addressing the post-operative and recovery market. Evome aims to enhance patient outcomes through its portfolio of devices utilized in rehabilitation settings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of an acquisition by Salona Global Medical Device Corporation, providing an update on a large potential acquisition, and highlighting the company's quarterly activities ending August 30, 2022 (Q2). It includes details about the acquisition terms, strategic plans, and management appointments. The document references that full financial results for the quarter will be filed later as interim financial statements with the SEC and Canadian securities regulators. The content focuses on acquisition and financing updates, integration plans, and operational highlights rather than presenting comprehensive financial statements or detailed earnings data. Therefore, this document is best classified as a Capital/Financing Update (CAP) since it primarily announces acquisition closings, financing negotiations, and strategic growth plans rather than being a full financial report or earnings release.
2022-09-26 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings
2022-09-20 English
Other.pdf
Regulatory Filings
2022-08-30 English
News release - English.pdf
Regulatory Filings
2022-08-29 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing management appointments (new CFO and President for a subsidiary) and a national sales distribution agreement. It discusses company growth, executive backgrounds, and strategic plans. There are no financial statements, quarterly or annual results, or detailed financial data. The document does not present an annual report, interim report, earnings release, or any audit information. It is primarily an announcement of changes in senior management and a business update regarding a distribution agreement. Therefore, it fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed information about management changes, supporting this classification with high confidence.
2022-08-22 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the execution of a letter of intent (LOI) and a binding purchase agreement for acquisitions by Salona Global Medical Device Corporation. It details the terms of the acquisitions, expected revenue impact, financing plans, and forward-looking statements about the transactions. There are no financial statements or detailed financial performance data presented, nor is this a regulatory filing or certification. The content focuses on acquisition announcements and financing arrangements related to these acquisitions. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including acquisition financing.
2022-08-15 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.